Fundraising Fox
NOVELLUS
Cambridge, US · Founded 2014 · Delaware LLC · 3 known investors
Find your way into NOVELLUS
Sign up to see every warm intro you have to NOVELLUS
- Paths you didn't know you had: your email and LinkedIn already hold routes to the NOVELLUS team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Novellus operates a technology platform for securities lending that lets institutional participants transact directly on a principal-to-principal basis, covering the full lifecycle including settlement and collateralization. It targets institutional market participants looking to in-source securities lending workflows.
Founders & leadership
NOVELLUS was founded in 2014 by Matthew Angel and Christopher Rohde.
Investors · 3
Reported raises · per SEC filings
Form D private placements$3M disclosed across 3 rounds · 2016–2018
▶$1MraisedMar 2018 · 1 investors · PharmaceuticalsRule 506(b)
- Christopher RohdeExecutive Officer, Director
- Matthew AngelDirector
- Offering amount
- $4M
- Amount sold
- $1M
- First sale
- Mar 2018
- Incorporated
- Limited Liability Company, Delaware, 2014
- Federal exemptions
- 06b
▶$1MraisedFeb 2017 · 1 investors · PharmaceuticalsRule 506(b)
- Matthew AngelDirector
- Christopher RohdeExecutive Officer, Director
- Offering amount
- $4M
- Amount sold
- $1M
- First sale
- Feb 2017
- Incorporated
- Limited Liability Company, Delaware, 2014
- Federal exemptions
- 06b
▶$1MraisedOct 2016 · 1 investors · PharmaceuticalsRule 506(b)
- Matthew AngelDirector
- Christopher RohdeDirector
- Offering amount
- $2.5M
- Amount sold
- $1M
- First sale
- Oct 2016
- Incorporated
- Limited Liability Company, Delaware, 2014
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Related companies · 1
Companies working in the same space as NOVELLUS.
Frequently asked questions
- What does NOVELLUS do?
- Novellus operates a technology platform for securities lending that lets institutional participants transact directly on a principal-to-principal basis, covering the full lifecycle including settlement and collateralization. It targets institutional market participants looking to in-source securities lending workflows.
- Who founded NOVELLUS?
- NOVELLUS was founded by Matthew Angel, Christopher Rohde in 2014.
- Who are NOVELLUS's investors?
- NOVELLUS's investors include Clocktower Ventures, FJ Labs, Thirdstream Partners.
- How much funding has NOVELLUS raised?
- NOVELLUS has disclosed $3M raised across 3 rounds.
- Where is NOVELLUS headquartered?
- NOVELLUS is headquartered in Cambridge, US.